Skip Navigation


Glycobiology Advance Access originally published online on February 9, 2008
Glycobiology 2008 18(5):384-394; doi:10.1093/glycob/cwn015
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow Supplementary Data
Right arrow Supplementary Data
Right arrow All Versions of this Article:
18/5/384    most recent
cwn015v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cederfur, C.
Right arrow Articles by Leffler, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cederfur, C.
Right arrow Articles by Leffler, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Different affinity of galectins for human serum glycoproteins: Galectin-3 binds many protease inhibitors and acute phase proteins

Cecilia Cederfur1,2, Emma Salomonsson2, Jonas Nilsson3, Adnan Halim3, Christopher T Öberg4, Göran Larson3, Ulf J Nilsson4 and Hakon Leffler1,2

2 Department of Laboratory Medicine, Section MIG (Microbiology, Immunology, Glycobiology), Lund University, 223-62 Lund
3 Department of Clinical Chemistry and Transfusion Medicine, University of Göteborg, Göteborg
4 Department of Organic Chemistry, Lund University, 222-41 Lund, Sweden


1 To whom correspondence should be addressed: Tel: +46-46-173273; Fax: +46-46-137468; e-mail: cecilia.cederfur{at}med.lu.se or hakon.leffler{at}med.lu.se

Received on October 4, 2007; revised on February 6, 2008; accepted on February 7, 2008

Here we report the first survey of galectins binding to glycoproteins of human serum. Serum was subjected to affinity chromatography using immobilized galectins, and the bound glycoproteins were analyzed by electrophoresis, Western blotting, and mass spectrometry. Galectins-3, -8, and -9 bound a much broader range of ligands in serum than previously known, galectin-1 bound less, and galectins-2, -4, and -7 bound only traces or no serum ligands. Galectin-3 bound most major glycoproteins, including alpha-2-macroglobulin and acute phase proteins such as haptoglobin. It bound only a selected minor fraction of transferrin, and bound none or little of IgG. Galectins-8 and -9 bound a similar range of glycoproteins as galectin-3, but in lower amounts, and galectin-8 had a relative preference for IgA. Galectin-1 bound mainly a fraction of alpha-2-macroglobulin and only traces of other glycoproteins. The binding of galectin-3 to serum glycoproteins requires affinity for LacNAc, since a mutant (R186S), which has lost this affinity, did not bind any serum glycoproteins. The average affinity of galectin-3 for serum glycoproteins was estimated to correspond to Kd ~1–5 µM by modeling of the affinity chromatography and a fluorescence anisotropy assay. Since galectins are expressed on endothelial cells and other cells exposed to serum components, this report gives new insight into function of galectins and the role of their different fine specificity giving differential binding to the serum glycoproteins.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
A. Karlsson, K. Christenson, M. Matlak, A. Bjorstad, K. L Brown, E. Telemo, E. Salomonsson, H. Leffler, and J. Bylund
Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils
Glycobiology, January 1, 2009; 19(1): 16 - 20.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H. Forsman, E. Salomonsson, K. Onnheim, J. Karlsson, A. Bjorstad, H. Leffler, J. Bylund, A. Karlsson, and C. Dahlgren
The {beta}-galactoside binding immunomodulatory lectin galectin-3 reverses the desensitized state induced in neutrophils by the chemotactic peptide f-Met-Leu-Phe: role of reactive oxygen species generated by the NADPH-oxidase and inactivation of the agonist
Glycobiology, November 1, 2008; 18(11): 905 - 912.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.